HADDOCK JASON (CFO) sold 76.3% of their position (96.71K shares) of ARRAY BIOPHARMA INC on the open market
Open‑market sale worth $2.11M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/8/2019ACC: 0001562180-19-000861
-96.71K
Net shares
Net seller
$2.11M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
85K acquired · 181.71K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−11.71K
Price / share
$20.00
Trade value
$234.24K
% of position
28.0%
2/6/2019
41.77K→30.06K
Common Stock
Direct
Shares
+85K
Price / share
$3.77
Trade value
$320.45K
% of position
282.8%
2/7/2019
30.06K→115.06K
Common Stock
Direct
Shares
−85K
Price / share
$22.05
Trade value
$1.87M
% of position
73.9%
2/7/2019
115.06K→30.06K
Total
Net shares
−11.71K
Net value
-$1.79M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2019 | S · Sale | −11.71K | $20.00 | $234.24K | 28.0% | 41.77K | 30.06K |
| Common Stock Direct | 2/7/2019 | M · Option Exercise | +85K | $3.77 | $320.45K | 282.8% | 30.06K | 115.06K |
| Common Stock Direct | 2/7/2019 | S · Sale | −85K | $22.05 | $1.87M | 73.9% | 115.06K | 30.06K |
| Total | −11.71K | -$1.79M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
85K shares
Shares
−85K
Strike price
3.77
Held after
404.45K
Exercisable
—
2/7/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock85K shares | 2/7/2019 | M · Option Exercise | −85K | 3.77 | — | 404.45K |